Increasing the influenza vaccination coverage in Poland: It is advisable, but is it possible?

In Europe, increases in the incidence of influenza are observed in regular annual epidemics from autumn to spring. Severe illness and complications are more frequent in certain risk groups, including children, persons with chronic medical conditions, and individuals aged 65 years and over. The main public health intervention to prevent influenza is vaccination. In order to protect vulnerable individuals and to reduce transmission vaccination is also recommended for healthcare professionals.
According to the European Centre for Disease Prevention and Control report “Seasonal influenza vaccination in Europe – Vaccination recommendations and coverage rates for eight influenza seasons” [1], seasonal influenza vaccination coverage rates among Polish children and adolescents did not exceed 4%. In the case of older age groups, a consensus was reached on an EU target of 75% vaccination coverage. So far, such coverage has only been reached in the Netherlands and the United Kingdom in some of the influenza seasons between 2008 and 2015. In Poland, seasonal influenza vaccination coverage among the older population is stable but only slightly exceeds 10%.
The latest systematic review of the cost-effectiveness of influenza immunisation found vaccination to be cost-effective for children, pregnant and postpartum women, high-risk groups, and, in some cases, healthy working-age adults [2]. Analysis conducted on data from Poland, including costs of hospitalisations and productivity loss, showed substantial possible economic savings for the Polish health care and social security system provided that the coverage rate was improved [3]. Increase in vaccination coverage would definitely be beneficial not only from a healthcare system perspective, but also on an individual level, by decreasing the probability of severe influenza and its complications in specific persons.
However, a considerable increase in vaccination coverage in Poland is unlikely to occur very quickly. First of all, very limited social trust in influenza vaccination is observed. According to the European Commission’s report “State of vaccine confidence in the EU 2018” [4], it is even lower than the trust in MMR (measles, mumps, and rubella) vaccination. This, partially at least, may have resulted from seasonal differentiation in efficacy of the influenza vaccine (dependent on the change in its composition) but also from perceived underestimation of the risks associated with influenza in the...


View full text...